Cargando…

Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18

The effects of transgenically encoded human and mouse IL-18 on T cell proliferation and its application in boosting chimeric antigen receptor (CAR) T cells are presented. Robust enhancement of proliferation of IL-18-secreting human T cells occurred in a xenograft model, and this was dependent on TCR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Biliang, Ren, Jiangtao, Luo, Yanping, Keith, Brian, Young, Regina M., Scholler, John, Zhao, Yangbing, June, Carl H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002762/ https://www.ncbi.nlm.nih.gov/pubmed/28954221 http://dx.doi.org/10.1016/j.celrep.2017.09.002

Ejemplares similares

A versatile system for rapid multiplex genome-edited CAR T cell generation
por: Ren, Jiangtao, et al.
Publicado: (2017)

IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models
por: Shi, Hongtai, et al.
Publicado: (2023)

Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL
por: Zhou, Wenping, et al.
Publicado: (2023)

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
por: Ren, Jiangtao, et al.
Publicado: (2017)

Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
por: Thakur, Archana, et al.
Publicado: (2021)

IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
por: Jaspers, Janneke E., et al.
Publicado: (2023)

IL-24 armored CAR19-T cells show enhanced antitumor activity and persistence
por: Hu, Qian, et al.
Publicado: (2021)

Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects
por: Zhou, Jianxia, et al.
Publicado: (2019)

CRISPR-edited CART with GM-CSF knockout and auto secretion of IL6 and IL1 blockers in patients with hematologic malignancy
por: Yi, Yan, et al.
Publicado: (2021)

IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
por: Zhou, Ting, et al.
Publicado: (2020)

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
por: Liu, Yifan, et al.
Publicado: (2023)

Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells
por: Mai, David, et al.
Publicado: (2023)

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2021)

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
por: Watanabe, Keisuke, et al.
Publicado: (2023)

The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
por: Janho dit Hreich, Serena, et al.
Publicado: (2023)

The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model
por: Mierzejewska, Jagoda, et al.
Publicado: (2022)

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
por: Rodriguez-Marquez, Paula, et al.
Publicado: (2022)

4071 Dynamic Control of Tumor Vessels Augments Antitumor Responses
por: Gabriel, Emmanuel M, et al.
Publicado: (2020)

Enhancing T cell persistence of CAR-redirected T cells in solid tumors
por: Guedan, Sonia, et al.
Publicado: (2014)

IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
por: Pang, Nengzhi, et al.
Publicado: (2021)

Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor
por: Schutsky, Keith, et al.
Publicado: (2015)

Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy
por: Chen, Xianhui, et al.
Publicado: (2021)

Engineering a HER2-CAR-NK Cell Secreting Soluble Programmed Cell Death Protein with Superior Antitumor Efficacy
por: Xia, Wenjiao, et al.
Publicado: (2023)

AIM2 inflammasome mediates Arsenic-induced secretion of IL-1 β and IL-18
por: Zhang, Mingfang, et al.
Publicado: (2016)

Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors
por: Li, Fanfan, et al.
Publicado: (2022)

Antitumor Effects of Berberine on Gliomas via Inactivation of Caspase-1-Mediated IL-1β and IL-18 Release
por: Tong, Lei, et al.
Publicado: (2019)

Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
por: Stüber, Tanja, et al.
Publicado: (2020)

Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer Model
por: Klampatsa, Astero, et al.
Publicado: (2020)

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
por: Jin, Linchun, et al.
Publicado: (2019)

Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
por: Li, You, et al.
Publicado: (2020)

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD(2) and Releasing Inducible IL-18
por: Glienke, Wolfgang, et al.
Publicado: (2022)

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
por: Watanabe, Keisuke, et al.
Publicado: (2018)

Arming NK cells with enhanced antitumor activity: CARs and beyond
por: Oberoi, Pranav, et al.
Publicado: (2013)

Incorporation of functional elements enhances the antitumor capacity of CAR T cells
por: Qin, Le, et al.
Publicado: (2017)

Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
por: Christodoulou, Ilias, et al.
Publicado: (2021)

Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19
por: Lu, Ting, et al.
Publicado: (2022)

Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses
por: Dangaj, Denarda, et al.
Publicado: (2013)

Distinct Licensing of IL-18 and IL-1β Secretion in Response to NLRP3 Inflammasome Activation
por: Schmidt, Rebecca L., et al.
Publicado: (2012)

Correction: Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
Publicado: (2020)

Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
por: Luo, Hong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7mbjuqmgv7t1tmsas1jqtup2mg